IN FOCUS: HIV/AIDS in 2012
University of California San Francisco
Give to UCSF
Trauma Drives HIV Epidemic in Women
Physical violence, sexual abuse and other forms of childhood and adult trauma are major factors fueling the epidemic of HIV/AIDS among American women, who account for at least 27 percent of new U.S. cases.
Confronting HIV in Oakland
<p>To effectively confront the HIV/AIDS epidemic in Oakland, the medical community needs to connect with African-American young men, who are a particularly vulnerable group of individuals who may not know they are at high risk and may not be receiving the information they need to protect themselves.</p>
White House Names San Francisco HIV/AIDS Leader to National Post
President Barack Obama appointed UCSF AIDS expert Grant Colfax, MD, as the director of the Office of National AIDS Policy.
Fighting Infections: Old Drug Reveals New Tricks
A drug once taken by people with HIV/AIDS, but long ago shelved after newer, modern antiretroviral therapies became available, has now shed light on how the human body uses its natural immunity to fight the virus — work that could help uncover new targets for drugs.
Paul Volberding Takes Leading Roles with UCSF's ARI, Global Health Sciences
<p>Paul Volberding, MD, one of the world's leading experts on treatment for patients infected with HIV, the AIDS virus, became the new director of the AIDS Research Institute (ARI) at UCSF on Feb. 13.</p>
Tenofovir, Leading HIV Medication, Linked with Risk of Kidney Damage
Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time, according to a study of more than 10,000 patients led by researchers at the San Francisco VA Medical Center and UCSF.
Tenofovir: Q&A for Patients and Providers
<p>Scientists at the San Francisco VA Medical Center and the University of California, San Francisco have published a study showing that one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, tenofovir, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time. See accompanying news release, <a href="http://ucsf.edu/news/2012/02/11508/tenofovir-leading-hiv-medication-linked-risk-kidney-damage">Tenofovir, Leading HIV Medication, Linked with Risk of Kidney Damage</a>.</p>